Skip to content

Imaging prediction and prognosis of hypertrophic olivary degeneration after brainstem or cerebellar hemorrhage

Prospective study on DTI-based quantification of Guillain-Mollaret triangle injury and hypertrophic olivary degeneration after brainstem/cerebellar hemorrhage

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129117
Enrollment
Unknown
Registered
2026-07-31
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic olivary degeneration after brainstem or cerebellar hemorrhage

Interventions

Group A: GMT injury positive and HOD positive Group B: GMT injury positive and HOD negative Group C: GMT injury negative and HOD negative:None

Sponsors

Mindong Hospital of Ningde City
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age 18 years or older; 2.Diagnosed with brainstem hemorrhage or cerebellar hemorrhage by cranial CT or MRI; 3.Able to complete MRI and DTI examinations within the predefined study time window after onset; 4.Complete clinical and imaging data are available, and the participant is able to complete follow-up and neurological functional assessments; 5.Written informed consent is obtained from the participant or legal representative;

Exclusion criteria

Exclusion criteria: 1.Previous diagnosis of hypertrophic olivary degeneration or pre-existing olivary lesions; 2.Severe traumatic brain injury, brain tumor, encephalitis, demyelinating disease, or other disorders that may affect the assessment of the brainstem, cerebellum, or related neural pathways; 3.Contraindications to MRI, such as a pacemaker, incompatible metallic implants, or severe claustrophobia; 4.Poor-quality imaging data that cannot be used for DTI post-processing or fiber tractography analysis; 5.Severe dysfunction of major organs or other serious conditions that preclude completion of follow-up; 6.Pregnancy or lactation; 7.Other conditions considered unsuitable for participation by the investigators;

Design outcomes

Primary

MeasureTime frame
Occurrence of HOD at 6-month follow-up;Early quantitative DTI parameters;

Secondary

MeasureTime frame
Fugl-Meyer Balance Scale score;modified Rankin Scale (mRS) score;Activities of Daily Living (ADL) scale score;Water Swallow Test (WST);

Countries

China

Contacts

Public ContactLin Lin

Mindong Hospital of Ningde City

790800164@qq.com+86 593 8981969

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026